Skip to main content
. 2020 Oct 14;10:571380. doi: 10.3389/fonc.2020.571380

FIGURE 2.

FIGURE 2

Immune signature analysis of inoperable locally advanced non-small-cell lung cancer (LA-NSCLC) patients (n = 100). (A) Immune signature distribution. (B) Survival status of inoperable LA-NSCLC patients. (C) Recurrence status of inoperable LA-NSCLC patients. (D) Color-gram of the expression profiles of five immune features in inoperable LA-NSCLC patients. Rows represent five immune features, and columns represent patients. Magenta dotted line represents the immune signature cutoff dividing the patients into high- and low-immune signature groups.